Filing Details

Accession Number:
0001181431-11-019083
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-03-18 17:57:07
Reporting Period:
2011-03-16
Filing Date:
2011-03-18
Accepted Time:
2011-03-18 17:57:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1131907 Micromet Inc. MITI Biological Products, (No Disgnostic Substances) (2836) 522243564
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1369942 Peter Johann C/O Ngn Capital Llc
Bergheimer Str 89A
Heidelberg 2M D-69115
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-03-16 5,000 $5.08 21,765 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,885,218 Indirect By fund
Common Stock 1,362,917 Indirect By fund
Footnotes
  1. These securities are held of record by NGN BioMed Opportunity I, L.P. ("NGN BioMed"). The reporting person is a Managing General Partner of NGN Capital LLC, which is the general partner of the general partner of NGN BioMed. The reporting person disclaims beneficial ownership of thesesecurities except to the extent of his pecuniary interest therein.
  2. These securities are held of record by NGN BioMed Opportunity I GmbH & Co. Beteiligungs KG ("NGN BioMed GmbH"). The reporting person is a Managing General Partner of NGN Capital LLC, which is the managing limited partner of NGN BioMed GmbH. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.